mortality/aging
• mutants die by 35 weeks of age due to heart failure
|
cardiovascular system
• degenerated cardiomyocytes with an increase in vacuolar formation and lysis of myofibrils
|
• increase in heart weight and ratio of heart weight to body weight
|
• left ventricular dimension is gradually increased
|
• cardiac fibrosis is seen at 10 months of age
|
• treatment of mutants with bisoprolol, a beta-blocker, ameliorates cardiac dysfunction
• treatment of mutants with KN-93, a CAMKII inhibitor, prevents left ventricular dilatation and preserves cardiac function
|
• decrease in cardiac systolic function at 10 months of age
|
• fractional shortening is reduced
|
• ECG indicates low amplitude of the R wave
|
• ECG does not show life-threatening arrhythmias, however spontaneous calcium sparks and calcium waves are increased in cardiomyocytes
• myofilaments exhibit a decrease in calcium sensitivity of force generation to a similar extent at both 2 and 10 months of age
|
cellular
• hearts show an increase in apoptotic cardiomyocytes at 5 months of age
|
muscle
• degenerated cardiomyocytes with an increase in vacuolar formation and lysis of myofibrils
|
• decrease in cardiac systolic function at 10 months of age
|
• fractional shortening is reduced
|
• hearts show an increase in apoptotic cardiomyocytes at 5 months of age
|
growth/size/body
• increase in heart weight and ratio of heart weight to body weight
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
dilated cardiomyopathy 1R | DOID:0110456 |
OMIM:613424 |
J:178587 |